O'Rourke Takes Helm at agilon health to Steer Next Growth Phase

WESTERVILLE, Ohio – April 27, 2026 – In a strategic move signaling a new chapter, agilon health (NYSE: AGL) today announced the appointment of Tim O’Rourke as its new Chief Executive Officer. Effective May 7, O’Rourke will also join the company’s Board of Directors, succeeding Ronald A. Williams, who has served as Executive Chairman and will now continue as Chairman of the Board.

The leadership transition comes as agilon, a company dedicated to empowering physicians in value-based care, emerges from a period of intense operational and financial restructuring. With a more stable foundation now in place, the board has tasked O'Rourke with leveraging his extensive experience to capitalize on the growing demand for physician-led senior care models.

“Tim is the right leader to take agilon forward,” said Ronald A. Williams, agilon's co-founder and incoming Chairman. “He has operated on both sides of the healthcare equation, from inside the world of distributed care delivery and across a leading Medicare Advantage payor, and brings a deep understanding of what is needed to succeed in value-based care.”

A New Chapter After Transformation

O’Rourke inherits a company that has undergone a significant, and at times painful, overhaul. Led by Williams, the recent transformation focused on shifting from aggressive growth to sustainable profitability. This pivot was a direct response to a challenging Medicare Advantage market and rising medical costs that have squeezed players across the industry.

Financially, the results of this transformation are beginning to show. While agilon health reported a substantial 40% revenue increase to $6.06 billion for fiscal year 2024, it also recorded a net loss of $260 million. However, the first quarter of 2025 marked a crucial turning point, with the company posting a net income of $12 million, a stark contrast to the $6 million loss in the same period a year prior. This improvement came despite a 4% year-over-year revenue decrease, a direct result of strategic exits from underperforming markets and payer contracts.

These moves are part of a broader strategy to fortify the company's core operations. The company is actively working to reduce its exposure to Medicare Part D, aiming to have less than 30% of its membership in these plans to mitigate cost volatility. Furthermore, its “2026 Transformation Initiative” is projected to yield an additional $125 million through improved contracting, while investments in AI-driven data analytics and the rollout of new clinical pathways aim to enhance both patient outcomes and financial performance. The company has publicly stated its goal of reaching cash flow breakeven by 2027, a target O'Rourke will now be responsible for achieving.

An Architect of Value-Based Care

To navigate this next phase, agilon's board has selected a leader whose career has been defined by the intersection of payers and providers. With over 25 years in healthcare, Tim O’Rourke brings a rare dual perspective to the CEO role.

Most recently, as President of Help at Home, he led a national provider of in-home care for complex senior and disabled patients, managing thousands of frontline caregivers. Before that, he spent 17 years in a variety of leadership roles at insurance giant Humana, where he developed deep expertise in Medicare Advantage. His roles included serving as CEO of Ascension Complete, a provider-integrated Medicare Advantage plan, and leading Humana's provider development and engagement strategies for over a million members.

This background makes him uniquely suited to lead agilon, a company whose entire model depends on the intricate partnership between physicians and health plans. His compensation package, which includes substantial equity grants tied to ambitious share-price goals of $50, $100, and $150 over three years, signals a strong alignment with delivering long-term shareholder value.

“agilon has built a distinct platform that puts primary care physicians at the center of how care is delivered and paid for in this country,” O’Rourke stated. “I’m energized by the opportunity to work alongside agilon’s physician partners and leadership team to support the company's performance and growth in the years ahead.”

Navigating a Dynamic Market

O’Rourke steps in at a time of immense momentum for the value-based care sector. The U.S. market is projected to grow at a compound annual rate of 7.4%, potentially reaching $4.01 trillion by 2030. This growth is fueled by a fundamental shift away from the traditional fee-for-service model, which pays for volume, toward models that reward providers for patient outcomes and cost efficiency.

Federal policy is a major tailwind, with the Centers for Medicare & Medicaid Services (CMS) aiming to have all traditional Medicare beneficiaries in a value-based, total care relationship by 2030. This policy goal creates a massive addressable market for companies like agilon that provide the infrastructure for physicians to take on financial risk for patient populations.

However, the path is not without challenges. The market is contending with regulatory uncertainty, persistent medical cost pressures, and the operational complexities of managing risk. Success requires sophisticated data analytics, strong physician buy-in, and significant capital, creating a high bar for participation.

A Differentiated Model in a Crowded Field

In this competitive environment, which includes diversified giants like CVS Health (owner of Oak Street Health) and UnitedHealth Group (owner of Optum), agilon has carved out a distinct niche. While some competitors acquire physician practices outright, agilon’s “Total Care Model” is built on 20-year partnerships that allow primary care groups to remain independent.

The company provides its partners—a network of approximately 2,300 primary care physicians—with the capital, technology, and analytics needed to transition to a full-risk model. Crucially, it provides 100% downside protection, removing a major barrier for physicians hesitant to move away from fee-for-service. This physician-centric approach is central to its identity.

“agilon was founded on the belief that empowering primary care physicians to manage the total health of their patients would produce better outcomes and a more sustainable healthcare system,” said Ravi Sachdev, agilon’s founder and Vice Chairman. “That mission is more relevant today than ever, and Tim shares our conviction in it.”

As CEO, O'Rourke will be tasked with scaling this differentiated model, proving its long-term financial viability, and steering the company through the complex and rapidly evolving landscape of American healthcare.